Icatibant

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 751 publications

Recurrent abdominal attacks as a presentation of hereditary angioedema type I: a multigenerational family series.

Recurrent abdominal attacks as a presentation of hereditary angioedema type I: a multigenerational family series.

Journal: Revista espanola de enfermedades digestivas
Published: June 10, 2026

First reported case of Andes hantavirus cardiopulmonary syndrome treated with a combination of favipiravir, ribavirin, icatibant and baricitinib.

First reported case of Andes hantavirus cardiopulmonary syndrome treated with a combination of favipiravir, ribavirin, icatibant and baricitinib.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: May 24, 2026

Could bradykinin pathway inhibition change the course of severe hantavirus disease?

Could bradykinin pathway inhibition change the course of severe hantavirus disease?

Journal: Immunology letters
Published: May 17, 2026

Modest Contribution of Bradykinin to Blood Pressure Reduction by Sacubitril/Valsartan in Chronic Heart Failure.

Modest Contribution of Bradykinin to Blood Pressure Reduction by Sacubitril/Valsartan in Chronic Heart Failure.

Journal: Circulation. Heart failure
Published: April 24, 2026

Diverse Trial Designs, Populations, and Outcomes: A Systematic Literature Review of Trials for the Treatment of Hereditary Angioedema Attacks.

Diverse Trial Designs, Populations, and Outcomes: A Systematic Literature Review of Trials for the Treatment of Hereditary Angioedema Attacks.

Journal: Advances in therapy
Published: April 09, 2026

Neprilysin Inhibitor and Angiotensin Receptor Blocker Attenuate Ischemic Brain Injury: Unveiling the Kinin-Mediated Pathway.

Neprilysin Inhibitor and Angiotensin Receptor Blocker Attenuate Ischemic Brain Injury: Unveiling the Kinin-Mediated Pathway.

Journal: Assay and drug development technologies
Published: March 10, 2026

Sebetralstat (Ekterly) for treatment of hereditary angioedema attacks.

Sebetralstat (Ekterly) for treatment of hereditary angioedema attacks.

Journal: The Medical letter on drugs and therapeutics
Published: February 06, 2026

Completion of the Icatibant Outcome Survey and What We Learned.

Completion of the Icatibant Outcome Survey and What We Learned.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: February 06, 2026

Halide-Mediated Electrochemical Peptide Synthesis Applicable to Highly Sterically Hindered Amino Acids.

Halide-Mediated Electrochemical Peptide Synthesis Applicable to Highly Sterically Hindered Amino Acids.

Journal: Organic letters
Published: February 05, 2026

Perioperative Hereditary Angioedema Triggered by Laryngeal Mask Airway: A Case Report and Anesthetic Implications.

Perioperative Hereditary Angioedema Triggered by Laryngeal Mask Airway: A Case Report and Anesthetic Implications.

Journal: Cureus
Published: December 22, 2025

Comparison of Clinical Characteristics Between Hereditary Angioedema Patients Aged 65 Years and Older and Those Under 65: A Perspective on Elderly Patients.

Comparison of Clinical Characteristics Between Hereditary Angioedema Patients Aged 65 Years and Older and Those Under 65: A Perspective on Elderly Patients.

Journal: Life (Basel, Switzerland)
Published: December 18, 2025

Non-peptide bradykinin B2 receptor ligands possessing the substituted quinolinyl moiety: Pharmacological properties and prospective clinical uses.

Non-peptide bradykinin B2 receptor ligands possessing the substituted quinolinyl moiety: Pharmacological properties and prospective clinical uses.

Journal: Peptides
Published: November 18, 2025
Showing 1-12 of 751

Last Updated: 06/30/2026